Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

ASPI US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

ASP Isotopes Inc.(ASPI US)

$1.23-0.1410.22%Ext:$1.17-0.064.76%(Market Closed · 00:56:07 UTC)
Ask AI
ProfileEntity StructureAll DocumentsFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings
Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

ASPI US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

ASP Isotopes Inc.(ASPI US)

$1.23-0.1410.22%Ext:$1.17-0.064.76%(Market Closed · 00:56:07 UTC)
Ask AI
ProfileEntity StructureAll DocumentsFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings
All Documents

Financials & Metrics

FinancialsChartingShort InterestEmployees
All Documents

Financials & Metrics

FinancialsChartingShort InterestEmployees

ASP Isotopes Inc. — Company Profile

ASP Isotopes Inc. is an emerging advanced materials company, currently in its pre-commercial stage. This firm is dedicated to the comprehensive management of isotopes, encompassing their creation, dissemination, promotion, and eventual sale. The company's developmental portfolio includes Molybdenum-100, a non-radioactive isotope designed for medical applications, alongside Carbon-14 and Silicon-28. Furthermore, ASP Isotopes is involved with Uranium-235, a specific uranium isotope considered crucial for the carbon-free energy sector. Established in 2021, the company maintains its headquarters in Boca Raton, Florida.

Sector
Basic Materials
Industry
Chemicals
Exchange
UQ
CEO
Paul Elliot Mann
Headquarters
Dallas, TX, US
IPO Date
Nov 10, 2022
Employees
271
Website
aspisotopes.com

Key Metrics

Price
$2.91
Market Cap
$366.38M
Revenue (TTM)
$4.18M
Net Income (TTM)
$-6878000.00
EPS (TTM)
-0.06
P/E (TTM)
-2.11
P/B (TTM)
1.27
Dividend Yield
0.00%
ROE (TTM)
-2.38%
ROA (TTM)
-1.17%
Operating Margin
-5.95%
Beta
3.38

Dividends

Last Dividend
$0.00
Last Yield
0.00%

Summary

ASP Isotopes Inc. is an emerging advanced materials company, currently in its pre-commercial stage. This firm is dedicated to the comprehensive management of isotopes, encompassing their creation, dissemination, promotion, and eventual sale. The company's developmental portfolio includes Molybdenum-100, a non-radioactive isotope designed for medical applications, alongside Carbon-14 and Silicon-28. Furthermore, ASP Isotopes is involved with Uranium-235, a specific uranium isotope considered crucial for the carbon-free energy sector. Established in 2021, the company maintains its headquarters in Boca Raton, Florida.

Website
aspisotopes.com
Location
Dallas, TX, US
Phone561 709 3034
Employees271
CEOPaul Elliot Mann
SectorBasic Materials
Industry
Chemicals
IPO DateNov 10, 2022

Latest Documents

SEC Filings(397)

Expand
  • Form 4Ainscow Robert18 Nov
  • SC 13G/AASP Isotopes Inc.16 Nov
  • Form 425Business combination communication6 Nov
  • Form 425Business combination communication5 Nov
  • Form 425Business combination communication26 Oct
  • 8-KRegulation FD Disclosure26 Oct
  • Form 4Kiessling Heather21 Oct
  • Form 4Ainscow Robert16 Oct
  • Form 144Kiessling Heather16 Oct
  • 8-KRegulation FD Disclosure15 Oct
  • Form 144Ainscow Robert14 Oct
  • Form 3ASP Isotopes Inc.8 Oct
  • SC 13DENDRA Life Sciences Inc.8 Oct
  • 8-KRegulation FD Disclosure2 Oct
  • Form 4Ryan Robert John Andrew1 Oct
  • Form 4Ryan Robert John Andrew30 Sep
  • Form 144Wider Todd25 Sep
  • Form 4Ainscow Robert10 Sep
  • Form 425Business combination communication9 Sep
  • Form 425Business combination communication9 Sep

News

  • ASP Isotopes Targets $300M EBITDA as Helium, Silicon-28 and Radiopharmacy Plans Advance28 Oct
  • ASP Isotopes Inc. Announces that Renergen Limited's Virginia Gas Project has Achieved Stable Liquid Helium Production26 Oct
  • Quantum Leap Energy and Necsa Sign Binding Heads of Agreement to Establish Joint Venture for HALEU Production in South Africa15 Oct
  • ASP Isotopes (NASDAQ:ASPI) Director Robert John Andrew Ryan Acquires 15,000 Shares of Stock2 Oct
  • Did ASP Isotopes Inc. Insiders Breach their Fiduciary Duties to Shareholders?28 Sep
  • Did ASP Isotopes Inc. Insiders Breach their Fiduciary Duties to Shareholders?28 Sep
  • ASP Isotopes Inc. (ASPI) Analyst/Investor Day Transcript9 Sep
  • ASP Isotopes Hosts Inaugural Capital Markets Day and Provides Operational Update8 Sep
  • BlackRock Inc. Purchases Shares of 9,217,198 ASP Isotopes Inc. $ASPI1 Sep
  • ASP Isotopes Nears Helium Production, Advances Stable Isotope Growth21 Aug
  • ASP Isotopes Inc. Announces that Renergen Limited's Subsidiary has Commenced Commissioning of Liquid Helium Plant in South Africa20 Aug
  • Presenting on Emerging Growth Conference 95 Day 2 on August 20; Register to live stream19 Aug

Mentions in Filings

  • … | | | | | | --- | --- | --- | --- | | ARBUTUS BIOPHARMA CORP | COMMON STOCK | 81,300 | 265,851 | | ARCADIUM LITHIUM PLC | COMMON STOCK USD1.0 | 594,548 | 3,050,031 | | ARCBEST CORP | COMMON STOCK USD.01 | 13,000 | 1,213,160 | | ARCELLX INC | COMMON STOCK USD.001 | 23,200 | 1,779,208 | | ARCH RESOURCES INC | COMMON STOCK USD.01 | 9,900 | 1,398,078 | | ARCHER AVIATION INC A | COMMON STOCK USD.0001 | 127,000 | 1,238,250 | | ARCHROCK INC | COMMON STO …
    INTERNATIONAL BUSINESS MACHINES CORPASP Isotopes Inc.·11-K - Annual report (employee stock purchase/savings/profit sharing plans)·FY24·13 Jun 2025

Key Stats

Trading

Px/Chg 1D$2.91 / +7.78%
Prev Close$4.20
% of 52Wk H29.12%
Avg Volume4.95M
Beta3.38
Mkt Cap366.38M
FD Mkt Cap531.31M

Float

Shrs Out/Float125.90M / 108.99M
Short Float0.35%
Days to Cover4.80
Stock Repurchased$0.00

Current Valuation

EV430.89M
EV/EBITDA-2.53
EV/Sales16.00
P/B1.27
P/S13.61
FCF Yield-6.52%
ROE-2.38%
ROA-1.17%
Current Ratio4.39

Estimates

P/E-2.11
Est P/E0.00
Est EPS-0.06
Est PEG0.00

Valuation

Metric5Yr AvgMay '23Aug '24May '25May '26Oct '26
PRICE-BASED RATIOS
Price / Earnings-15.51-2.40-4.28-12.95-5.76-52.17
Price / Sales75.040.00161.12101.0327.2085.84
Price / Book Value4.011.216.638.742.221.24
Price / Free Cash Flow-14.09-1.60-16.55-14.92-22.38-15.02
ENTERPRISE VALUE METRICS
Enterprise Value269.210.372.5397.8442.2423.3
Enterprise Value / Sales78.240.00167.3795.9926.55101.28
Enterprise Value / EBITDA-9.14-2.09-4.49-12.60-7.14-19.39
Enterprise Value / EBIT-8.60-2.09-4.48-12.41-7.03-17.01

Financials

Full Financials
Millions USD5Yr CAGR (%)Dec '21Dec '22Dec '23Dec '24Dec '25
INCOME STATEMENT
Revenue—--0.44.123.8
Gross Income—-0.0-0.11.63.4
EBITDA179.1%-2.6-4.9-16.1-31.6-157.1
EBIT179.4%-2.6-4.9-16.2-32.1-159.0
Net Income186.2%-2.6-4.9-16.3-32.3-175.1
EPS (Diluted)129.6%-0.08-0.13-0.49-0.63-2.11
BALANCE SHEET
Cash & ST Inv225.9%3.02.47.961.9333.3
Total Assets191.1%7.112.530.294.3512.9
Total Liabilities284.4%1.12.711.443.2250.0
Total Shareholder Equity141.5%6.09.816.347.9204.2
CASH FLOW
Net Operating Cash Flow184.4%-0.6-2.9-5.4-16.7-37.8
Cap Ex34.1%-3.0-4.5-2.3-11.4-9.7
Free Cash Flow91%-3.6-7.4-7.7-28.1-47.4

Enterprise Value Bridge

Millions USD18 Nov '26
Price (As of 18 Nov '26)1.23
Basic Shares125.90
Market Cap154.9
Diluted Shares122.72
Fully Diluted Shares Outstanding122.72
Fully Diluted Market Cap150.9
+Consolidated Debt269.6
−In-the-Money Convertible Debt—
+Capital Leases5.3
+Operating Leases—
−Cash & Equivalents-219.6
−Short-term Investments-35.3
+Total Preferred-
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest10.1
+Pension Liabilities—
Enterprise Value215.0

Segment data

Revenue

by Products and services

  • Product100%

Related companies

Element Solutions Inc

ESI US

Cabot Corp

CBT US

Wd 40 Co

WDFC US

Flotek Industries Inc/cn/

FTK US

Orion S.A.

OEC US

Arq, Inc.

ARQ US

NEXT-ChemX Corporation.

CHMX US

PV Nano Cell, Ltd.

PVNNF US

Versum Materials, Inc.

VSM XS

ASP Isotopes Inc. — Company Profile

ASP Isotopes Inc. is an emerging advanced materials company, currently in its pre-commercial stage. This firm is dedicated to the comprehensive management of isotopes, encompassing their creation, dissemination, promotion, and eventual sale. The company's developmental portfolio includes Molybdenum-100, a non-radioactive isotope designed for medical applications, alongside Carbon-14 and Silicon-28. Furthermore, ASP Isotopes is involved with Uranium-235, a specific uranium isotope considered crucial for the carbon-free energy sector. Established in 2021, the company maintains its headquarters in Boca Raton, Florida.

Sector
Basic Materials
Industry
Chemicals
Exchange
UQ
CEO
Paul Elliot Mann
Headquarters
Dallas, TX, US
IPO Date
Nov 10, 2022
Employees
271
Website
aspisotopes.com

Key Metrics

Price
$2.91
Market Cap
$366.38M
Revenue (TTM)
$4.18M
Net Income (TTM)
$-6878000.00
EPS (TTM)
-0.06
P/E (TTM)
-2.11
P/B (TTM)
1.27
Dividend Yield
0.00%
ROE (TTM)
-2.38%
ROA (TTM)
-1.17%
Operating Margin
-5.95%
Beta
3.38

Dividends

Last Dividend
$0.00
Last Yield
0.00%

Summary

ASP Isotopes Inc. is an emerging advanced materials company, currently in its pre-commercial stage. This firm is dedicated to the comprehensive management of isotopes, encompassing their creation, dissemination, promotion, and eventual sale. The company's developmental portfolio includes Molybdenum-100, a non-radioactive isotope designed for medical applications, alongside Carbon-14 and Silicon-28. Furthermore, ASP Isotopes is involved with Uranium-235, a specific uranium isotope considered crucial for the carbon-free energy sector. Established in 2021, the company maintains its headquarters in Boca Raton, Florida.

Website
aspisotopes.com
Location
Dallas, TX, US
Phone561 709 3034
Employees271
CEOPaul Elliot Mann
SectorBasic Materials
Industry
Chemicals
IPO DateNov 10, 2022

Latest Documents

SEC Filings(397)

Expand
  • Form 4Ainscow Robert18 Nov
  • SC 13G/AASP Isotopes Inc.16 Nov
  • Form 425Business combination communication6 Nov
  • Form 425Business combination communication5 Nov
  • Form 425Business combination communication26 Oct
  • 8-KRegulation FD Disclosure26 Oct
  • Form 4Kiessling Heather21 Oct
  • Form 4Ainscow Robert16 Oct
  • Form 144Kiessling Heather16 Oct
  • 8-KRegulation FD Disclosure15 Oct
  • Form 144Ainscow Robert14 Oct
  • Form 3ASP Isotopes Inc.8 Oct
  • SC 13DENDRA Life Sciences Inc.8 Oct
  • 8-KRegulation FD Disclosure2 Oct
  • Form 4Ryan Robert John Andrew1 Oct
  • Form 4Ryan Robert John Andrew30 Sep
  • Form 144Wider Todd25 Sep
  • Form 4Ainscow Robert10 Sep
  • Form 425Business combination communication9 Sep
  • Form 425Business combination communication9 Sep

News

  • ASP Isotopes Targets $300M EBITDA as Helium, Silicon-28 and Radiopharmacy Plans Advance28 Oct
  • ASP Isotopes Inc. Announces that Renergen Limited's Virginia Gas Project has Achieved Stable Liquid Helium Production26 Oct
  • Quantum Leap Energy and Necsa Sign Binding Heads of Agreement to Establish Joint Venture for HALEU Production in South Africa15 Oct
  • ASP Isotopes (NASDAQ:ASPI) Director Robert John Andrew Ryan Acquires 15,000 Shares of Stock2 Oct
  • Did ASP Isotopes Inc. Insiders Breach their Fiduciary Duties to Shareholders?28 Sep
  • Did ASP Isotopes Inc. Insiders Breach their Fiduciary Duties to Shareholders?28 Sep
  • ASP Isotopes Inc. (ASPI) Analyst/Investor Day Transcript9 Sep
  • ASP Isotopes Hosts Inaugural Capital Markets Day and Provides Operational Update8 Sep
  • BlackRock Inc. Purchases Shares of 9,217,198 ASP Isotopes Inc. $ASPI1 Sep
  • ASP Isotopes Nears Helium Production, Advances Stable Isotope Growth21 Aug
  • ASP Isotopes Inc. Announces that Renergen Limited's Subsidiary has Commenced Commissioning of Liquid Helium Plant in South Africa20 Aug
  • Presenting on Emerging Growth Conference 95 Day 2 on August 20; Register to live stream19 Aug

Mentions in Filings

  • … | | | | | | --- | --- | --- | --- | | ARBUTUS BIOPHARMA CORP | COMMON STOCK | 81,300 | 265,851 | | ARCADIUM LITHIUM PLC | COMMON STOCK USD1.0 | 594,548 | 3,050,031 | | ARCBEST CORP | COMMON STOCK USD.01 | 13,000 | 1,213,160 | | ARCELLX INC | COMMON STOCK USD.001 | 23,200 | 1,779,208 | | ARCH RESOURCES INC | COMMON STOCK USD.01 | 9,900 | 1,398,078 | | ARCHER AVIATION INC A | COMMON STOCK USD.0001 | 127,000 | 1,238,250 | | ARCHROCK INC | COMMON STO …
    INTERNATIONAL BUSINESS MACHINES CORPASP Isotopes Inc.·11-K - Annual report (employee stock purchase/savings/profit sharing plans)·FY24·13 Jun 2025

Key Stats

Trading

Px/Chg 1D$2.91 / +7.78%
Prev Close$4.20
% of 52Wk H29.12%
Avg Volume4.95M
Beta3.38
Mkt Cap366.38M
FD Mkt Cap531.31M

Float

Shrs Out/Float125.90M / 108.99M
Short Float0.35%
Days to Cover4.80
Stock Repurchased$0.00

Current Valuation

EV430.89M
EV/EBITDA-2.53
EV/Sales16.00
P/B1.27
P/S13.61
FCF Yield-6.52%
ROE-2.38%
ROA-1.17%
Current Ratio4.39

Estimates

P/E-2.11
Est P/E0.00
Est EPS-0.06
Est PEG0.00

Valuation

Metric5Yr AvgMay '23Aug '24May '25May '26Oct '26
PRICE-BASED RATIOS
Price / Earnings-15.51-2.40-4.28-12.95-5.76-52.17
Price / Sales75.040.00161.12101.0327.2085.84
Price / Book Value4.011.216.638.742.221.24
Price / Free Cash Flow-14.09-1.60-16.55-14.92-22.38-15.02
ENTERPRISE VALUE METRICS
Enterprise Value269.210.372.5397.8442.2423.3
Enterprise Value / Sales78.240.00167.3795.9926.55101.28
Enterprise Value / EBITDA-9.14-2.09-4.49-12.60-7.14-19.39
Enterprise Value / EBIT-8.60-2.09-4.48-12.41-7.03-17.01

Financials

Full Financials
Millions USD5Yr CAGR (%)Dec '21Dec '22Dec '23Dec '24Dec '25
INCOME STATEMENT
Revenue—--0.44.123.8
Gross Income—-0.0-0.11.63.4
EBITDA179.1%-2.6-4.9-16.1-31.6-157.1
EBIT179.4%-2.6-4.9-16.2-32.1-159.0
Net Income186.2%-2.6-4.9-16.3-32.3-175.1
EPS (Diluted)129.6%-0.08-0.13-0.49-0.63-2.11
BALANCE SHEET
Cash & ST Inv225.9%3.02.47.961.9333.3
Total Assets191.1%7.112.530.294.3512.9
Total Liabilities284.4%1.12.711.443.2250.0
Total Shareholder Equity141.5%6.09.816.347.9204.2
CASH FLOW
Net Operating Cash Flow184.4%-0.6-2.9-5.4-16.7-37.8
Cap Ex34.1%-3.0-4.5-2.3-11.4-9.7
Free Cash Flow91%-3.6-7.4-7.7-28.1-47.4

Enterprise Value Bridge

Millions USD18 Nov '26
Price (As of 18 Nov '26)1.23
Basic Shares125.90
Market Cap154.9
Diluted Shares122.72
Fully Diluted Shares Outstanding122.72
Fully Diluted Market Cap150.9
+Consolidated Debt269.6
−In-the-Money Convertible Debt—
+Capital Leases5.3
+Operating Leases—
−Cash & Equivalents-219.6
−Short-term Investments-35.3
+Total Preferred-
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest10.1
+Pension Liabilities—
Enterprise Value215.0

Segment data

Revenue

by Products and services

  • Product100%

Related companies

Element Solutions Inc

ESI US

Cabot Corp

CBT US

Wd 40 Co

WDFC US

Flotek Industries Inc/cn/

FTK US

Orion S.A.

OEC US

Arq, Inc.

ARQ US

NEXT-ChemX Corporation.

CHMX US

PV Nano Cell, Ltd.

PVNNF US

Versum Materials, Inc.

VSM XS